PVMCV
Polaris Venture Management Co V Portfolio holdings
AUM
$14.1M
This Quarter Return
-22.14%
1 Year Return
+121.41%
3 Year Return
+278.88%
5 Year Return
+1,121.38%
10 Year Return
–
AUM
$93.2M
AUM Growth
+$93.2M
(-11%)
Cap. Flow
+$22.1M
Cap. Flow
% of AUM
23.76%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
10
New
1
Increased
–
Reduced
3
Closed
–
Top Buys
| 1 |
Cartesian Therapeutics
RNAC
|
$26.9M |
Top Sells
| 1 |
TRVN
Trevena, Inc.
TRVN
|
$2.51M |
| 2 |
Ocular Therapeutix
OCUL
|
$1.15M |
| 3 |
TTOO
T2 Biosystems, Inc
TTOO
|
$1.13M |
Sector Composition
| 1 | Healthcare | 83.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Cartesian Therapeutics
RNAC
$256M
| $26.9M | 28.9% |
+1,924,151
| New | +$26.9M |
|
|
TTOO
2
DELISTED
T2 Biosystems, Inc
TTOO
| $14.8M | 15.89% |
1,875,524
-142,926
| -7% | -$1.13M |
|
|
TRVN
3
DELISTED
Trevena, Inc.
TRVN
| $14.3M | 15.35% |
2,270,319
-398,961
| -15% | -$2.51M |
|
|
GNCA
4
DELISTED
Genocea Biosciences, Inc.
GNCA
| $8.07M | 8.66% |
1,968,606
| – | – |
|
5
Pulmatrix
PULM
$17.4M
| $7.07M | 7.59% |
3,607,996
| – | – |
|
6
Dare Bioscience
DARE
$27.4M
| $6.97M | 7.48% |
3,287,529
| – | – |
|
|
ATYR
7
aTyr Pharma
ATYR
$554M
| $5.08M | 5.46% |
1,827,992
| – | – |
|
|
8
Ocular Therapeutix
OCUL
$2.21B
| $4.94M | 5.31% |
998,713
-231,296
| -19% | -$1.15M |
|
9
Fate Therapeutics
FATE
$119M
| $4.2M | 4.51% |
2,473,186
| – | – |
|
|
BIND
10
DELISTED
BIND THERAPEUTICS INC
BIND
| $789K | 0.85% |
2,018,253
| – | – |
|